Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oral curcumin supplementation in dry age-related macular degeneration; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Age Related Macular Degeneration | EARLY_Phase 1 | Status: COMPLETED